Fact CheckerSign in

NCT04687033Completed

The Effect of The Ten-Session Dual-tDCS On Lower-Limb Performance in Sub- Acute and Chronic Stroke

Source: ClinicalTrials.gov · Last updated 18 Nov 2025

Brief summary (registry, in English)

The present study aims to determine the effect of the ten-session dual tDCS combine with physical therapy on gait performance, balance, and lower limbs muscle strength in patients with subacute and chronic stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
34 (actual)
First submitted
9 Dec 2020
Start date
1 Jan 2021
Primary completion date
30 Nov 2023
Lead sponsor
Mahidol University
Diseases
Stroke
NCT number
NCT04687033

What you commit to

  • Study type: Interventional
  • Participants enrolled: 34
  • From 1 Jan 2021 to the primary completion date, 30 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Clinical unstable such as vital sign unstable (systolic blood pressure (SBP) ≥ 185 mmHg or diastolic blood pressure (DBP) ≥ 110 mmHg (98) and resting heart rate averaging ≥ 100 bpm (99))
  • No clear neurological antecedent history or psychiatric disorder
  • Unstable medical conditions such as being in the middle of changing medical treatment.
  • Condition that may increase the risk of stimulation such as epilepsy, pregnancy, unexplained headaches, intracranial metal, pacemaker (evaluating by subjective examination).

Other

  • Not cooperative or cannot understand the instruction
  • Moderate pain in any joint of both lower limb (Pain Scale (VAS) ≥ 4/10)
  • Participate in the other protocol or receive alternative treatment such as transcranial magnetic stimulation within 1 month.

Who the study is looking for

  • Age range 20-75 years
  • First ever-ischemic lesion in the territory of middle cerebral artery or anterior cerebral artery. Diagnostic confirmation will be performed by CT scan or MRI
  • Sub-acute onset (1-6 months after the stroke onset) or Chronic (6 months - 5 years)
  • Able to walk without physical assistance at least 6 meters

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mahidol University
Coordinator of this site? Confirm its status
Nakhon PathomThailandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.